Risks and benefits of TIPS in HCC and other liver malignancies: a literature review

BACKGROUND: Transjugular intrahepatic portosystemic shunt (TIPS) is a well-validated treatment option for clinically significant portal hypertension (CSPH) in the context of liver cirrhosis. Its high efficacy and safety in the management of treatment-refractory ascites and variceal bleeding have bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Fichtl, Anna, Seufferlein, Thomas, Zizer, Eugen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662760/
https://www.ncbi.nlm.nih.gov/pubmed/37986043
http://dx.doi.org/10.1186/s12876-023-03047-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662760/
https://www.ncbi.nlm.nih.gov/pubmed/37986043
http://dx.doi.org/10.1186/s12876-023-03047-0

Ejemplares similares